Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Director/PDMR Shareholding

27 Jul 2018 15:30

RNS Number : 0577W
Phoenix Group Holdings
27 July 2018
 

The PDMRs listed in the table were each granted awards under the Long Term Incentive Plan ("LTIP") over Ordinary Shares of €0.0001 each fully paid in the Company in 2015, 2016, 2017 and 2018. Further to the recent Rights Issue the number of shares subject to the awards have been adjusted for each PDMR as per the Company's LTIP scheme rules relating to capital reorganisations and as also approved by the Group Remuneration Committee.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Clive Bannister (Group Chief Executive)

James McConville (Group Finance Director)

Stephen Jefford (Group HR Director)

Tony Kassimiotis (Group Chief Operating Officer)

Susan McInnes (Group Chief Risk Officer)

Andrew Moss (Chief Executive, Phoenix Life)

Rakesh Thakrar (Deputy Finance Director)

Simon True (Group Corporate Development Director and Group Chief Actuary)

Quentin Zentner (General Counsel)

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

As noted in 1a) above

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Phoenix Group Holdings

b)

 

LEI

 

 

21380031B1D56JRCE375

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Phoenix Group Holdings Ordinary Shares of €0.0001

 

KYG7091M1096

 

b)

 

Nature of the transaction

 

 

Share Options Acquired under the LTIP following Rights Issue Adjustment

c)

 

Price(s) and volume(s)

 

 

 

Director/PDMR

 

Increase in shares subject to Awards following adjustment

 

Clive Bannister (Director)

22,286 (2015 Grant)

21,020 (2016 Grant)

19,899 (2017 Grant)

20,043 (2018 Grant)

 

James McConville (Director)

14,008 (2015 Grant)

13,212 (2016 Grant)

12,508 (2017 Grant)

12,598 (2018 Grant)

 

Stephen Jefford

(PDMR)

3,157 (2016 Grant)

2,984 (2017 Grant)

3,292 (2018 Grant)

 

Tony Kassimiotis (PDMR)

7,163 (2015 Grant)

6,756 (2016 Grant)

6,396 (2017 Grant)

6,442 (2018 Grant)

 

Susan McInnes (PDMR)

 

1,910 (2015 Grant)

1,801 (2016 Grant)

1,812 (2017 Grant)

3,149 (2018 Grant)

 

Andrew Moss

(PDMR)

7,521 (2015 Grant)

7,770 (2016 Grant)

7,995 (2017 Grant)

8,053 (2018 Grant)

 

Rakesh Thakrar (PDMR)

2,507 (2015 Grant)

2,364 (2016 Grant)

2,288 (2017 Grant)

3,579 (2018 Grant)

 

Simon True

(PDMR)

7,709 (2015 Grant)

7,271 (2016 Grant)

7,038 (2017 Grant)

7,516 (2018 Grant)

 

Quentin Zentner (PDMR)

5,253 (2015 Grant)

5,180 (2016 Grant)

5,116 (2017 Grant)

5,583 (2018 Grant)

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

As noted in 4c) above

 

 

Nil

e)

 

Date of the transaction

 

 

27 July 2018

f)

 

Place of the transaction

 

 

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHSELFLWFASESW
Date   Source Headline
24th Feb 20262:25 pmRNSChange of Company Name
18th Feb 20262:12 pmRNSAppointment of Corporate Broker
6th Feb 20261:52 pmRNSDirector/PDMR Shareholding
2nd Feb 202611:02 amRNSTotal Voting Rights
6th Jan 20261:31 pmRNSDirector/PDMR Shareholding
2nd Jan 202611:06 amRNSTotal Voting Rights
18th Dec 20252:38 pmRNSCompletion of Redemption at Maturity
18th Dec 20252:38 pmRNSCompletion of Redemption at Maturity
12th Dec 20252:49 pmRNSBlock listing Return
8th Dec 202511:08 amRNSDirector/PDMR Shareholding
1st Dec 20251:57 pmRNSTotal Voting Rights
24th Nov 20255:20 pmRNSBlock Listing Application
24th Nov 20257:09 amRNSLIST 2025 Results Show Robust Capital Position
6th Nov 20253:47 pmRNSDirector/PDMR Shareholding
3rd Nov 202512:01 pmRNSTotal Voting Rights
31st Oct 20253:10 pmRNSDirector/PDMR Shareholding
7th Oct 20251:20 pmRNSDirector/PDMR Shareholding
1st Oct 202512:38 pmRNSTotal Voting Rights
17th Sep 20252:40 pmRNSPublication of a Supplementary Prospectus
10th Sep 20252:51 pmRNSDirector/PDMR Shareholding
8th Sep 20255:23 pmRNSDirector/PDMR Shareholding
8th Sep 20257:00 amRNS2025 Interim Results
1st Sep 202510:00 amRNSTotal Voting Rights
18th Aug 202510:00 amRNSBoard Changes
6th Aug 202512:53 pmRNSDirector/PDMR Shareholding
1st Aug 202510:18 amRNSTotal Voting Rights
8th Jul 20253:31 pmRNSDirector/PDMR Shareholding
1st Jul 202512:26 pmRNSTotal Voting Rights
26th Jun 20259:00 amRNSBoard Changes
13th Jun 20253:00 pmRNSPublication of Prospectus
12th Jun 20252:43 pmRNSBlock listing Return
9th Jun 202512:25 pmRNSDirector/PDMR Shareholding
2nd Jun 202512:44 pmRNSTotal Voting Rights
23rd May 20253:02 pmRNSDirector/PDMR Shareholding
20th May 202510:00 amRNSDirector Declaration
13th May 20253:34 pmRNSResult of AGM
7th May 20254:20 pmRNSDirector/PDMR Shareholding
1st May 202510:33 amRNSTotal Voting Rights
10th Apr 20252:37 pmRNSDirector/PDMR Shareholding
8th Apr 20253:10 pmRNSDirector/PDMR Shareholding
3rd Apr 20251:35 pmRNSNotice of AGM
1st Apr 20252:52 pmRNSDirector/PDMR Shareholding
1st Apr 20252:42 pmRNSTotal Voting Rights
26th Mar 20253:46 pmRNSDirector/PDMR Shareholding
24th Mar 20255:43 pmRNSDirector/PDMR Shareholding
21st Mar 202511:56 amRNSDirector/PDMR Shareholding
20th Mar 20254:19 pmRNSDirector/PDMR Shareholding
19th Mar 20254:26 pmRNSDirector/PDMR Shareholding
19th Mar 20252:15 pmRNSDirector/PDMR Shareholding
17th Mar 20257:00 amRNS2024 Annual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.